Quantifying patient preferences for bacillus Calmette-Guérin (BCG) and PD-(L)1 inhibitors in high-risk non-muscle invasive bladder cancer (NMIBC): A discrete choice experiment. This is an ASCO Meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results